Benzoyl Formic Acid

Benzoyl Formic Acid

SCHEMBL2132689

NC(=O)N1CCCCC1.O=C(O)C(=O)c1ccccc1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.58
ALDH1A1 P00352 4/20 0.51
USP2 O75604 1/20 0.51
GAA P10253 1/20 0.50
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CYP2C9 P11712 1/20 0.46
TP53 P04637 1/20 0.46
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.43
CES2 O00748 1/20 0.43
CES1 P23141 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isophthalic Acid SCHEMBL5411490 0.79 HPGD (0.56) HPGDALDH1A1USP2GAAMEN1
SCHEMBL5564719 0.78 HPGD (0.66) HPGDALDH1A1USP2GAAMEN1
Isophthalic Acid SCHEMBL5406230 0.77 HPGD (0.57) HPGDALDH1A1USP2GAAMEN1
(Z)-1,2-Diphenylethene SCHEMBL29161028 0.77 KMT2A (0.56) HPGDALDH1A1USP2GAAMEN1
Oxalic Acid SCHEMBL6984891 0.77 ALDH1A1 (0.48) HPGDALDH1A1HTT
Terephthalic Acid SCHEMBL5406537 0.76 HPGD (0.52) HPGDALDH1A1GAATP53MAPK1
SCHEMBL12489727 0.76 HPGD (0.62) HPGDALDH1A1USP2GAAMEN1
Benzamide SCHEMBL23174921 0.75 HPGD (0.61) HPGDALDH1A1USP2GAAMEN1
SCHEMBL19380449 0.75 PHGDH (0.70) HPGDALDH1A1USP2GAAMEN1
SCHEMBL7749269 0.74 ALDH1A1 (0.55) HPGDALDH1A1MEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999036403-A1 NOVEL DOPAMINE RE-UPTAKE INHIBITORS AND METHODS OF SYNTHESIZING AND USING THE SAME THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1999-07-22 WO claimed
US-9463187-B2 Methylphenidate derivatives and uses of them AMPIO PHARMACEUTICALS, INC. (US) 2016-10-11 US disclosed
US-20120101129-A1 Methylphenidate Derivatives and Uses of Them AMPIO PHARMACEUTICALS, INC. 2012-04-26 US disclosed
US-8076485-B2 Methylphenidate derivatives and uses of them INSTITUTE FOR MOLECULAR MEDICINE, INC. (US) 2011-12-13 US disclosed
WO-1999036403-A1 NOVEL DOPAMINE RE-UPTAKE INHIBITORS AND METHODS OF SYNTHESIZING AND USING THE SAME THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1999-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120101129-A1 Methylphenidate Derivatives and Uses of Them SLC6A3, COMT, UGT1A1 HPGD 2196/4885ALDH1A1 335/4885USP2 2656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.